Journal of Clinical and Experimental Ophthalmology
Open Access

Experience against COVID-19 Pandemic in Ophthalmology

Liwen Chen, Xuhui Chen, Hao Du, Chaohua Deng, Xian Zhang, Bo Chen and Xufang Sun^{* *}Correspondence: Xufang Sun, Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China, Email:

Author info »

Introduction

At present, the COVID-19 pandemic has emerged signs of stable or in control, especially in China. For ophthalmologists, it is necessary to summarize researches on COVID-19 related ocular characteristics and the experience against the SARS-CoV-2 infection.

Commentary

The transmission of SARS-CoV-2 via the ocular surface eyes should not be overlooked. It has been proved that the entry of SARS cov-2 is mediated by angiotensin converting enzyme 2 (ACE2), a metallopeptidase expressed in many human tissues, including the cornea and conjunctiva [1,2]. Besides, a novel route of CD147 (extracellular matrix metalloproteinase inducer) -spike protein (SP) was found in promoting SARS-CoV-2 invasion into host cells [3]. CD147 was also detected in cornea, conjunctiva and retina [4]. Further study of animal model showed that macaques could be infected with SARS-CoV-2 via the conjunctival route and the viruses spread in both nasolacrimal system and lung [5]. These results provide a molecular basis for the transmission of SARS-CoV-2 through the eyes.

A lot of case reports and observational studies suggested that conjunctival congestion was one of the symptoms of COVID-19, and could appear as the initial symptom [6-9]. Our paper, titled “Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: A cross-sectional study ” , enrolled 535 patients at Mobile Cabin Hospital and Tongji Hospital with mild COVID-19. 5.0% patients had conjunctival congestion during hospitalization. Moreover, the average duration of conjunctival congestion was 5.9 ± 4.5 days (mean [SD]). We further investigated the behaviors of eye protection, showing that frequent hand-eye contact may be the risk factor for conjunctival congestion in COVID-19 patients. For these patients with conjunctivitis, the usage of ganciclovir eye drop was effective.

Except for the ocular manifestations of conjunctivitis, such as conjunctival congestion, chemosis, increased watery secretions or tearing, no symptom and lesion associated with intraocular diseases (iritis, choroiditis, and retinal disease) was found in COVID-19 patients, which suggested that the illness seemed to confine to the ocular surface [7,9,10]. Recent researches has proved that SARS-CoV-2 spike (S)-protein binds ACE2, and in concert with host proteases, principally TMPRSS2, promotes cellular entry [11]. Co-expression of ACE2 and TMPRSS2 was detected in conjunctiva and cornea but not in retina, in accordance with the clinical symptoms [12]. Thus, screening of patients with ocular surface discomforts by ophthalmologists is advocated during the outbreak of COVID-19.

In the early stage of the epidemic in Wuhan, China, most of the infected medical staffs worked not in respiratory or emergency department but in neurosurgery or ophthalmology departments. In the early stage of the epidemic in Wuhan, China, most of the infected medical staffs worked not in respiratory or emergency department but in neurosurgery or ophthalmology departments.

For patients, online doctor visit via smartphone could help reducing face-to-face contact. If the preliminary treatments fail to relieve the ocular discomforts, patients are then asked to make an appointment on “Tongji hospital” application before going to the clinic. All patients are advised to wear masks everywhere in hospital and they are firstly screened through temperature measurement and symptoms at emergency department. A series of examinations, including blood routine, COVID-19 IgM/IgG detection, SARS-CoV-2 detection in nasopharyngeal swabs and chest CT are needed for patients with high temperature, respiratory symptoms, close contact with COVID-19 diagnosed patients or before ocular surgery.

For ophthalmologists, personal protective equipment (PPE), N95 mask, goggle and face mask are necessary dealing with COVID-19 patients. We recommend iCare rebound tonometer to evaluate IOP, but not non-contact tonometer which will produce local aerosol in the process [13]. Protective shields can be added to the slit lamp microscope. Proper ventilation and instrument disinfection are also very important performing ophthalmologic examinations. During the epidemic in our ward, glaucoma operation and ROP treatment are the most common emergency surgery, while eye trauma surgery is relatively rare because of the home quarantine. To reduce the risk of cross-infection, operation methods should be considered that minimized follow-up frequency and time spent in hospital. Another challenge is anaesthesia, we use local anaesthesia as often as possible for adults and laryngeal mask anaesthesia for children [14]. Ordinary goggles seriously impede microsurgery. We replace it with homemade goggles by sealing the own glasses or flat lenses around the eyes with plastic wrap and remove the plastic wrap from the centre of the lens to get clear vision.

In addition to the above managements, it is crucial to educate both patients and practitioners to understand the ocular characteristics of COVID-19 and eye protection. Our group collected the opinions of COVID-19 related eye protection among 133 medical staffs and 174 common Wuhan residents. Although 65.4% medical staffs considered conjunctival congestion as one of the symptoms of COVID-19, less than one third residents knew this. Notably, 67.1% medical staffs washed their hands before touching eyes, while only 21.1% common residents did the same. Therefore, public health education, especially hand hygiene, still needs to be enhanced.

Conclusion

In conclusion, conjunctival congestion is one of the COVID-19 related ocular symptoms, which could occur as the initial symptoms. Ophthalmologists should pay attention to the selfprotection during examinations and surgery. It is also essential to provide eye-care equipment and strengthen health education on hand hygiene. Hopefully, our experience, to some extent, will help ophthalmologists and patients worldwide.

References

1. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol. 2020;94:e00127-20.
2. Yan S, Xin P, Lin L, Canrong N. Expression of SARS coronavirus S protein functional receptor ACE2 in human and rabbit cornea and conjunctiva. Rec Adv Ophthalmol.2004;24: 332-336.
3. Wang K, Chen W, Zhou YS, Lian JQ, Zhang Z, Du P, et al. (2020) SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. Biorxiv.2020:03(14);988345.
4. Maatta M, Tervahartiala T, Kaarniranta K, Tang Y, Yan L, et al. Immunolocalization of EMMPRIN (CD147) in the human eye and detection of soluble form of EMMPRIN in ocular fluids. Curr Eye Res.2006;31: 917-24.
5. Deng W, Bao L, Gao H, Xiang Z, Qu Y, Song Z, et al. (2020) Rhesus macaques can be effectively infected with SARS-CoV-2 via ocular conjunctival route. BioRxiv: 2020.03.13.990036.
6. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med.2020,382: 1708–1720.
7. Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, Wu K. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol.2020;138(5):575-578.
8. Zhang X, Chen X, Chen L, Deng C, Zou X, et al. The evidence of SARS-CoV-2 infection on ocular surface. Ocul Surf.2020;18:360-362.
9. Cheema M, Aghazadeh H, Nazarali S, Ting A, Hodges J, McFarlane A, Kanji JN, Zelyas N, Damji KF, Solarte C. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19): A case report. Canadian J Ophthalmol.2020; S0008-4182(20)30305-7.
10. Chen L, Liu M, Zhang Z, Qiao K, Huang T, Chen M, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. British Journal of Ophthalmology. 2020;104(6):748-751.
11. Ziegler CG, Allon SJ, Nyquist SK, Mbano IM, Miao VN, TzouanasCN, et al. (2020) SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell.2020; S0092-8674(20)30500-6.
12. Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020:1-7.
13. Britt JM, Clifton BC, Barnebey HS, Mills RP. Microaerosol formation in noncontact'air-puff'tonometry. Arch Ophthalmol.1991;109(2):225-8.
14. Du H, Zhang M, Zhang H, Sun X. Practical experience on emergency ophthalmic surgery during the prevalence of COVID-19. Graefe's Archive for Clinical and Experimental Ophthalmology.2020;1-3.